CD4+, CD8+ T cells, as well as Th1 and Th17 cells, are well‐recognized as anti‐tumor immune cells, and their degree of infiltration is positively correlated with prognosis [47, 48, 49]. This evidence concerns the gene CD8A and neoplasm.